A series of (ethoxycarbonylpiperazinyl)- and piperazinyl-1,8-naphthyridine
derivatives, variously substituted, has been synthesized and pharmacologica
lly investigated for anthihypertensive activity. Some of them exhibited a s
ignificant and prolonged decrease of the mean arterial pressure (MAP) on sp
ontaneously hypertensive rats. On the basis of the pharmacological results,
no structure-activity relationship can be deduced at this time. Moreover,
the most active compound 4e, was investigated by means of in vitro pharmaco
logical functional studies and in vivo, as a diuretic agent, to determine a
possible mechanism of the antihypertensive activity, which results in a pr
obably non-competitive antagonism against alpha(1), vascular adrenoceptors.
This mechanism was also shown by the compounds 8 and 13. (C) Elsevier, Par
is.